Target intelligence / Profile preview

Cardiac muscle regeneration

Molecular classification
Other (not a single molecule or receptor; refers to a biological process)
01

Overview

Cardiac muscle regeneration refers to the biological process by which damaged heart muscle tissue is repaired or replaced following injury such as myocardial infarction. In adult mammals—including humans—this regenerative capacity is extremely limited because most cardiomyocytes are terminally differentiated and have low proliferative potential. Research has focused on stimulating endogenous repair mechanisms through activation or transplantation of cardiac stem/progenitor cells expressing markers like c-Kit and Sca-1, manipulation of key signaling pathways such as Hippo-Yap/Wnt/β-catenin, and modulation by microRNAs that regulate cell cycle reentry in mature cardiomyocytes. While promising strategies exist—including gene therapy targeting these pathways or delivery of exogenous progenitor/stem cells—cardiac muscle regeneration remains an area under active investigation rather than a defined molecular target suitable for direct drug interaction. Thus "cardiac muscle regeneration" describes a complex physiological phenomenon rather than an individual therapeutic target molecule/receptor.

Other names
Myocardial regenerationHeart muscle regenerationCardiac regeneration
02

Mechanism of action

Not applicable for a process; mechanisms include modulation of signaling pathways like Hippo-Yap, Wnt/β-catenin, Notch signaling, miRNA-mediated gene regulation.

03

Biological functions

Cell proliferationTissue repairCell cycle regulationDifferentiation of cardiac progenitor cellsActivation of endogenous cardiac stem cells
04

Disease associations

Cardiovascular disease (especially myocardial infarction and heart failure)Other (general tissue injury and repair contexts)
05

Safety considerations

Risk of arrhythmia from uncontrolled cardiomyocyte proliferationFibrosis instead of functional tissue formation after injuryImmune rejection in cell-based therapies
06

Biomarkers

c-Kit/Sca-1 expression on cardiac stem cellsLevels of specific miRNAs associated with cardiomyocyte proliferation

Beyond the preview

Go deeper on Cardiac muscle regeneration.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardiac muscle regeneration.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call